It was another good year for life science industry executives as venture capital investment continued to rise. How does your company compare?
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
<http://www.compstudy.com>
Rychlik, B. & DiPierro, M. Nat. Biotechnol. 24, 1599–1600 (2006).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rychlik, B., DiPierro, M. Executive compensation at private biotech companies: a competitive environment. Nat Biotechnol 26, 133–134 (2008). https://doi.org/10.1038/nbt0108-133
Issue Date:
DOI: https://doi.org/10.1038/nbt0108-133
This article is cited by
-
Executive compensation at private life science companies in troubled economic times
Nature Biotechnology (2009)